Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
about
Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@en
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@nl
type
label
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@en
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@nl
prefLabel
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@en
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@nl
P2093
P2860
P356
P1476
Combined inhibition of JAK1,2/ ...... cancer to NK cells in hypoxia.
@en
P2093
Bo-Xin Xue
Chuan-Yang Sun
Dong-Rong Yang
Ya-Chen Zang
Yi-Bin Zhou
P2860
P304
P356
10.3892/MMR.2018.8905
P577
2018-04-20T00:00:00Z